Leptin in relation to carcinoma In situ of the breast: A study of pre-menopausal cases and controls

✍ Scribed by Christos S. Mantzoros; Kari Bolhke; Stergios Moschos; Daniel W. Cramer

• Publisher: John Wiley and Sons
• Year: 1999
• Tongue: French
• Weight: 48 KB
• Volume: 80
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/(sici)1097-0215(19990209)80:4<523::aid-ijc7>3.0.co;2-c

✦ Synopsis

Leptin reflects the amount of energy stores, regulates energy balance and is associated with circulating levels of reproductive hormones and insulin-like growth factor-I (IGF-I). Breast cancer has also been associated with obesity, reproductive hormones and circulating IGF-I levels. To determine whether leptin is involved in the etiology of breast cancer, we compared serum leptin levels in 83 cases of pre-menopausal carcinoma in situ of the breast and 69 healthy controls recruited in Massachusetts. Serum leptin levels were 13.69 ؉ 1.3 ng/ml in cases and 16.03 ؉ 1.7 ng/ml in controls. Data were also analyzed using multiple logistic regression with adjustment for known risk factors for the development of breast cancer as well as anthropometric, demographic and hormonal variables, including estradiol, prolactin, IGF-I and IGF-binding protein-3. Odds ratios were 1.75 (95% CI, 0.73-4.21) for the second control-defined tertile and 1.54 (0.46-5.16 ) for the third control-defined tertile relative to the first. Thus, leptin does not appear to increase the risk of premenopausal breast cancer in situ substantially.